U.S. FDA

@FDA

Our posts are FDA Approved! Privacy Policy - go.usa.gov/xFfG8 FDA Authentic Accounts - bit.ly/FDASocial

Silver Spring, MD

fda.gov

Replies Reposts Media

U.S. FDA
@FDA
21h
We’re advancing the Trump Administration's commitment to safe, nutritious infant formula. Today, we issued a proposed rule that, if finalized, would update some infant formula nutrient requirements. fda.gov/food/infant-fo…
7
U.S. FDA
@FDA
Oct 28
Today, FDA kicked off its Rare Disease Framework Initiative with a public meeting, co-hosted by @reaganudall. Thanks to all who joined for your input, candor & vision. With only 5% of rare diseases having an approved treatment, the status quo isn't enough — we must do more. FDA
25
U.S. FDA
@FDA
Oct 28
Reminder: Join the FDA Oncology Center of Excellence for a virtual Conversations on Cancer panel, Navigating Cancer Resources in the Digital Age, on Thursday, Oct. 29 at 2:00 PM ET. Learn how cancer patients and caregivers navigate online health information. Watch free:
3
U.S. FDA
@FDA
Oct 27
#DYK that nearly 1/2 of U.S. women over 40 have dense breast tissue — and that can make it harder to detect cancer on a #mammogram? This #BreastCancerAwarenessMonth, get the facts about #BreastDensity and why it matters from FDA Office of Women’s Health.
1
U.S. FDA
@FDA
Oct 27
Modernizing FDA's review process starts with listening. Acting Commissioner Kyle Diamantas joined @RareDiseases at the #NORDSummit Monday to discuss how patient voices are central to building a fit-for-purpose framework for #RareDisease therapies.
National Organization for Rare Disorders (NORD)
@RareDiseases
Oct 26
Acting @FDA Commissioner Kyle Diamantas, @FDA_KyleD, sat down for a fireside chat with #NORD President and CEO Pam Gavin to kick off the 2026 #NORDSummit, where he shared that the #FDA is committed to modernizing its review process and is relying on #RareDisease patient voices to
16